In 2024, the global oral proteins and peptides market was valued at USD 1.8 billion. Forecasts by IMARC Group indicate robust growth, with the market expected to hit USD 3.4 billion by 2033, reflecting a CAGR of 7.13% from 2025 to 2033. North America, with a market share exceeding 97.8% in 2024, dominates the sector. Key growth factors include technological advancements in drug delive... https://www.imarcgroup.com/oral-proteins-peptides-market